| 000 | 01275 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516011357.0 | ||
| 264 | 0 | _c20110923 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1872-8294 | ||
| 024 | 7 |
_a10.1016/j.addr.2010.10.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMuller, Patrick Y | |
| 245 | 0 | 0 |
_aComparative requirements for exploratory clinical trials -- eIND, eCTA and microdosing. _h[electronic resource] |
| 260 |
_bAdvanced drug delivery reviews _cJun 2011 |
||
| 300 |
_a511-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 |
_aBiotechnology _xmethods |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aClinical Trials, Phase I as Topic _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDrugs, Investigational _xadministration & dosage |
| 650 | 0 | 4 | _aGuidelines as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInternational Cooperation |
| 650 | 0 | 4 | _aModels, Biological |
| 773 | 0 |
_tAdvanced drug delivery reviews _gvol. 63 _gno. 7 _gp. 511-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.addr.2010.10.010 _zAvailable from publisher's website |
| 999 |
_c20334657 _d20334657 |
||